Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts.
Lanino L, Restuccia F, Perego A, Ubezio M, Fattizzo B, Riva M, Consagra A, Musto P, Cilloni D, Oliva EN, Palmieri R, Poloni A, Califano C, Capodanno I, Itri F, Elena C, Fozza C, Pane F, Pelizzari AM, Breccia M, Di Bassiano F, Crisà E, Ferrero D, Giai V, Barraco D, Vaccarino A, Griguolo D, Minetto P, Quintini M, Paolini S, Sanpaolo G, Sessa M, Bocchia M, Di Renzo N, Diral E, Leuzzi L, Genua A, Guarini A, Molteni A, Nicolino B, Occhini U, Rivoli G, Bono R, Calvisi A, Castelli A, Di Bona E, Di Veroli A, Ferrara F, Fianchi L, Galimberti S, Grimaldi D, Marchetti M, Norata M, Frigeni M, Sancetta R, Selleri C, Tanasi I, Tosi P, Turrini M, Giordano L, Finelli C, Pasini P, Naldi I, Santini V, Della Porta MG; Fondazione Italiana Sindromi Mielodisplastiche (FISiM) Clinical network (https://www.fisimematologia.it/). Lanino L, et al. Among authors: palmieri r. Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24. Am J Hematol. 2023. PMID: 37222267 Free article. No abstract available.
Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy.
Maurillo L, Spagnoli A, Candoni A, Papayannidis C, Borlenghi E, Lazzarotto D, Fianchi L, Sciumè M, Zannier ME, Buccisano F, Del Principe MI, Mancini V, Breccia M, Fanin R, Todisco E, Lunghi M, Palmieri R, Fracchiolla N, Musto P, Rossi G, Venditti A. Maurillo L, et al. Among authors: palmieri r. Leuk Res. 2023 Apr;127:107040. doi: 10.1016/j.leukres.2023.107040. Epub 2023 Feb 14. Leuk Res. 2023. PMID: 36801702
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials.
Luciano L, Latagliata R, Gugliotta G, Annunziata M, Tiribelli M, Martino B, Sica A, Esposito MR, Bocchia M, Galimberti S, Sorà F, Albano F, Palmieri R, Pregno P, Dragani M, Iovine M, Sica S, Iurlo A, Castagnetti F, Rosti G, Breccia M. Luciano L, et al. Among authors: palmieri r. Ann Hematol. 2023 Jun;102(6):1375-1382. doi: 10.1007/s00277-023-05159-9. Epub 2023 Apr 20. Ann Hematol. 2023. PMID: 37079069 Free PMC article.
Editorial: Measurable residual disease in hematologic malignancies.
Buccisano F, Palmieri R, Guzman ML, Galimberti S. Buccisano F, et al. Among authors: palmieri r. Front Oncol. 2023 May 10;13:1204393. doi: 10.3389/fonc.2023.1204393. eCollection 2023. Front Oncol. 2023. PMID: 37234991 Free PMC article. No abstract available.
Fever of Unknown Origin and Multidrug Resistant Organism Colonization in AML Patients.
Guarnera L, Trotta GE, Boldrini V, Cardillo L, Cerroni I, Mezzanotte V, Pasqualone G, Savi A, Borsellino B, Buzzatti E, Palmieri R, Paterno G, Maurillo L, Buccisano F, Venditti A, Del Principe MI. Guarnera L, et al. Among authors: palmieri r. Mediterr J Hematol Infect Dis. 2023 Jan 1;15(1):e2023013. doi: 10.4084/MJHID.2023.013. eCollection 2023. Mediterr J Hematol Infect Dis. 2023. PMID: 36660358 Free PMC article.
Therapy-related Myeloid Neoplasms: Considerations for Patients' Clinical Evaluation.
Palmieri R, Paterno G, Mallegni F, Frenza F, De Bernardis I, Moretti F, Meddi E, Del Principe MI, Maurillo L, Venditti A, Buccisano F. Palmieri R, et al. Mediterr J Hematol Infect Dis. 2023 Sep 1;15(1):e2023051. doi: 10.4084/MJHID.2023.051. eCollection 2023. Mediterr J Hematol Infect Dis. 2023. PMID: 37705524 Free PMC article. Review.
The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia.
Paterno G, Palmieri R, Tesei C, Nunzi A, Ranucci G, Mallegni F, Moretti F, Meddi E, Tiravanti I, Marinoni M, Page C, Fagiolo S, Buzzatti E, Secchi R, Gurnari C, Maurillo L, Buccisano F, Venditti A, Del Principe MI. Paterno G, et al. Among authors: palmieri r. Thromb Res. 2024 Apr;236:30-36. doi: 10.1016/j.thromres.2024.02.017. Epub 2024 Feb 16. Thromb Res. 2024. PMID: 38387301 Free article.
Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis.
Falconi G, Galossi E, Fabiani E, Pieraccioli M, Travaglini S, Hajrullaj H, Cerretti R, Palmieri R, Latagliata R, Maurillo L, Voso MT. Falconi G, et al. Among authors: palmieri r. Sci Rep. 2022 Dec 8;12(1):21231. doi: 10.1038/s41598-022-24644-1. Sci Rep. 2022. PMID: 36481766 Free PMC article.
225 results